Dip

Stocks rebounded from Tuesday’s sell-off to post across-the-board gains Wednesday, as investors re-embraced the long-term promise of the artificial intelligence (AI) revolution. The main U.S. equity indexes were …

By Deena Beasley (Reuters) -Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for its new …